| Name | Title | Contact Details |
|---|
WIDTHMAN USA is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. Our strategic and iterative approach enables us to create, build and deploy a myriad of accessible tests customized to meet and empower the user at their point of need. With a panoramic vision spanning the present to the future, we develop trusted solutions that are both intuitive and secure to use. We quickly and nimbly became the world`s largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic conditions and wellness.
GNYHA Ventures is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ethicon Endo Surgery is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.